Behavioral activation intervention, whether delivered by specialists or non-specialists, was effective for the treatment of perinatal depression and anxiety.
This task force does not recommend universal, instrument-based screening for perinatal depression because we lack clear evidence that screening improves outcomes.
This initiative will gauge mental health clinicians’ experience with and attitudes around treating pregnant women with mental and substance use disorders in order to identify training gaps.
While depression is relatively common in pregnancy and we have data to support the reproductive safety of many different antidepressants, many women are reluctant to use antidepressant medications during pregnancy. Because untreated depression in [...]
Over the last few years, the medical community has been using the term perinatal mood and anxiety disorders (PMADs) to describe the spectrum of psychological symptoms women may experience during pregnancy or the postpartum period. [...]
Perinatal mood and anxiety disorders (PMADs) including prenatal depression (PND) and postpartum depression (PPD) can have a profound adverse impact on the well-being of mothers, newborns, and entire families. It is estimated that 20%-25% [...]
In the Boston area, the number of people hospitalized for COVID-19 is steadily decreasing. This is obviously happy news and a long-awaited reason to celebrate; however, we continue to be concerned about the mental [...]
